Cyr61/CCN1 targets for chemosensitization in pancreatic cancer
Oncotarget
.
2019 Jun 4;10(38):3579-3580.
doi: 10.18632/oncotarget.26986.
Authors
Snigdha Banerjee
1
,
Arnab Ghosh
1
,
Daniel D VonHoff
1
,
Sushanta K Banerjee
1
Affiliation
1
Cancer Research Unit, VA Medical Center, Kansas City, MO, USA; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
PMID:
31217893
PMCID:
PMC6557211
DOI:
10.18632/oncotarget.26986
No abstract available
Keywords:
Cyr61; chemoresistance; gemcitabine; pancreatic cancer.
Publication types
Editorial
Grants and funding
I01 BX001002/BX/BLRD VA/United States